Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed 
VARON Enhances Customer Access to Oxygen Concentrators Through Its Official Online Store
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- As more individuals, families, and caregivers research oxygen therapy solutions online, knowing where to...
Glidewell Introduces Simply Natural(TM) 3D Flexible Partials
3D-printed prosthesis from America's No. 1 digital dental lab offers streamlined delivery and predictable outcome. NEWPORT BEACH, CALIFORNIA / ACCESS...
Allied OMS Enters New Jersey with Partnership with Oral & Maxillofacial Surgery of Central New Jersey
Two-location practice strengthens Allied's East Coast footprint and brings nationally recognized surgical expertise into the network SOUTHLAKE, TX AND MERCERVILLE,...
Medical Care Technologies (OTC PINK:MDCE) Advances First AI-Powered Mobile Application Toward Launch on Google Play and Apple App Store
MESA, AZ / ACCESS Newswire / December 19, 2025 / Medical Care Technologies, Inc. (OTC PINK:MDCE) today announced that its...
New Horizon Medical Solutions Establishes Multispecialty Medical Advisory Board to Advance Evidence-Based Wound Care Innovation
Board unites nationally recognized clinical leaders to guide product development, regulatory alignment and real-world adoption LAS VEGAS, NV / ACCESS...
2,000+ Volunteer Hours: DaVita Teammates Connect With Communities During Week of Service
NORTHAMPTON, MA / ACCESS Newswire / December 19, 2025 / DaVita: A DaVita teammate helps organize medically tailored meals as...
Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China
Regulatory clearance of Bentrio in allergic rhinitis for Mainland ChinaNearly 200 million Chinese estimated to suffer from allergic rhinitisBentrio to...
Cosmos Health is Forcing the Market to Reframe the Conversation
CHICAGO, IL / ACCESS Newswire / December 19, 2025 / For a long stretch, Cosmos Health (NASDAQ:COSM) sat in a...
1933 Industries Issues Reminder to Debenture Holders Ahead of December 22 Conversion Deadline and Highlights Positive Industry Developments
VANCOUVER, BC / ACCESS Newswire / December 19, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF) is...
Remedy’s Nutrition® Launches Mega VMT™ High-Potency Multivitamin to Revolutionize Daily Energy and Nutritional Wellness
KEY LARGO, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Remedy's Nutrition®, a trusted natural dietary supplement company since 1972 and...
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company’s Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or...
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
Financing included participation by healthcare-dedicated investors alongside existing shareholdersTORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (Nasdaq:PROF; TSX:PRN)...
Amplia Enters into Second Agreement with Korean Specialist Drug Screening Company Next&Bio to Explore Combination Therapy with FAK Inhibitor and kRAS Inhibitors
HIGHLIGHTS The preclinical research collaboration with specialist drug screening company Next & Bio has been extendedThe collaboration explores the effect...
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals
ATHENS, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals, Inc.’s (OTC: NDTP) wholly-owned subsidiary Good Salt Life, Inc., a pioneer...
Sienna Completes Acquisition in the Greater Toronto Area
This news release constitutes a “designated news release” for the purposes of Sienna’s amended and restated prospectus supplement dated November...
Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses
The PL-16 Viral Blocker has shown over 90% success in protection of cells against viruses Raanana, Israel, Dec. 19, 2025...
Outlook Therapeutics Reports Financial Results for Fiscal Year 2025
ISELIN, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the...
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
CAMBRIDGE, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and...
Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027
NORCROSS, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with...
Cue Biopharma Announces Pricing of $10 Million Public Offering
BOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class...